Overall Exposure of European Adult Population to Mycotoxins by Statistically Modelled Biomonitoring Data

Overview

Journal Toxins (Basel)

Publisher MDPI

Specialty Toxicology

Date 2021 Oct 22

PMID 34678988

Citations 8

Authors

Barbara De Santis

Francesca Debegnach

Piero Toscano

Alfonso Crisci

Paola Battilani

Carlo Brera

Affiliations

Soon will be listed here.

Abstract

This study presents the exposure scenario to mycotoxins of adult population throughout Europe. The urinary biomarkers values were obtained by modelling data from two European projects. Exposure to AFB1, OTA, CIT, FBs, DON, NIV and T2/HT2 are presented. The main output obtained refers to a concern for public health about AFM1, FBs, T2/HT2 and NIV, and low concern for OTA, DON and CIT. The margin of exposure for AFM1 did not respect the reference value of 10,000 considered of low priority for risk; for toxins, FBs and T2/HT2, probable daily intake (PDI) values resulted about ten times higher than their tolerable daily intake and NIV presented the most critical situation with a calculated PDI 30 times higher than the reference TDI value. North and South Europe scenarios were also depicted by clustering biomonitoring data. OTA and DON showed to be prevalent in Northern countries and the opposite was noticed for ZEN, higher in Southern countries. The critical issues of the availability of records feeding the dataset and of the accuracy of excretion rate for some mycotoxins are source of uncertainty for the reliability of the outputs, nevertheless the time is ripe for asking for more concrete HBM values and/or HBM-HBGV which would help in interpreting the burden of mycotoxins in Europe.

Citing Articles

Prevalence and health risk evaluations of mycotoxins in drinking water sources in Nigeria.

Koko D, Alfred M, Bolujoko N, Olorunnisola D, Otitoju O, Alabi P RSC Adv. 2024; 14(46):34435-34447.

PMID: 39473792 PMC: 11520314. DOI: 10.1039/d4ra04866k.

Assessment of Mycotoxin Exposure and Associated Risk in Pregnant Dutch Women: The Human Biomonitoring Approach.

McKeon H, Schepens M, van den Brand A, de Jong M, van Gelder M, Hesselink M Toxins (Basel). 2024; 16(6).

PMID: 38922172 PMC: 11209130. DOI: 10.3390/toxins16060278.

Frequent Dietary Multi-Mycotoxin Exposure in UK Children and Its Association with Dietary Intake.

Charusalaipong P, Gordon M, Cantlay L, De Souza N, Horgan G, Bates R Toxins (Basel). 2024; 16(6).

PMID: 38922145 PMC: 11209425. DOI: 10.3390/toxins16060251.

An Occurrence Study of Mycotoxins in Plant-Based Beverages Using Liquid Chromatography-Mass Spectrometry.

Pavlenko R, Berzina Z, Reinholds I, Bartkiene E, Bartkevics V Toxins (Basel). 2024; 16(1).

PMID: 38251269 PMC: 10821093. DOI: 10.3390/toxins16010053.

What Is Fusarium Head Blight (FHB) Resistance and What Are Its Food Safety Risks in Wheat? Problems and Solutions-A Review.

Mesterhazy A Toxins (Basel). 2024; 16(1).

PMID: 38251247 PMC: 10820574. DOI: 10.3390/toxins16010031.

References

Gambacorta L, Olsen M, Solfrizzo M . Pig Urinary Concentration of Mycotoxins and Metabolites Reflects Regional Differences, Mycotoxin Intake and Feed Contaminations. Toxins (Basel). 2019; 11(7). PMC: 6669694. DOI: 10.3390/toxins11070378. View

Goodrum P, Anderson J, Luz A, Ansell G . Application of a Framework for Grouping and Mixtures Toxicity Assessment of PFAS: A Closer Examination of Dose-Additivity Approaches. Toxicol Sci. 2020; 179(2):262-278. PMC: 7846094. DOI: 10.1093/toxsci/kfaa123. View

Knutsen H, Barregard L, Bignami M, Bruschweiler B, Ceccatelli S, Cottrill B . Appropriateness to set a group health based guidance value for nivalenol and its modified forms. EFSA J. 2020; 15(4):e04751. PMC: 7009959. DOI: 10.2903/j.efsa.2017.4751. View

Ali N, Degen G . Urinary biomarkers of exposure to the mycoestrogen zearalenone and its modified forms in German adults. Arch Toxicol. 2018; 92(8):2691-2700. DOI: 10.1007/s00204-018-2261-5. View

Arce-Lopez B, Lizarraga E, Vettorazzi A, Gonzalez-Penas E . Human Biomonitoring of Mycotoxins in Blood, Plasma and Serum in Recent Years: A Review. Toxins (Basel). 2020; 12(3). PMC: 7150965. DOI: 10.3390/toxins12030147. View

Battilani P, Toscano P, van der Fels-Klerx H, Moretti A, Camardo Leggieri M, Brera C . Aflatoxin B1 contamination in maize in Europe increases due to climate change. Sci Rep. 2016; 6:24328. PMC: 4828719. DOI: 10.1038/srep24328. View

Degen G . Are we ready to estimate daily ochratoxin A intake based on urinary concentrations?. Environ Int. 2015; 97:254-255. DOI: 10.1016/j.envint.2015.10.010. View

Knutsen H, Alexander J, Barregard L, Bignami M, Bruschweiler B, Ceccatelli S . Risks to human and animal health related to the presence of deoxynivalenol and its acetylated and modified forms in food and feed. EFSA J. 2020; 15(9):e04718. PMC: 7010102. DOI: 10.2903/j.efsa.2017.4718. View

Christensen K, Makris S, Lorber M . Generation of hazard indices for cumulative exposure to phthalates for use in cumulative risk assessment. Regul Toxicol Pharmacol. 2014; 69(3):380-9. DOI: 10.1016/j.yrtph.2014.04.019. View

10.

Mahdavi R, Nikniaz L, Arefhosseini S, Vahed Jabbari M . Determination of aflatoxin M(1) in breast milk samples in Tabriz-Iran. Matern Child Health J. 2008; 14(1):141-5. DOI: 10.1007/s10995-008-0439-9. View

11.

Degen G, Ali N, Gundert-Remy U . Preliminary data on citrinin kinetics in humans and their use to estimate citrinin exposure based on biomarkers. Toxicol Lett. 2017; 282:43-48. DOI: 10.1016/j.toxlet.2017.10.006. View

12.

More S, Bampidis V, Benford D, Bennekou S, Bragard C, Halldorsson T . Guidance on harmonised methodologies for human health, animal health and ecological risk assessment of combined exposure to multiple chemicals. EFSA J. 2020; 17(3):e05634. PMC: 7009070. DOI: 10.2903/j.efsa.2019.5634. View

13.

Knutsen H, Barregard L, Bignami M, Bruschweiler B, Ceccatelli S, Cottrill B . Appropriateness to set a group health based guidance value for T2 and HT2 toxin and its modified forms. EFSA J. 2020; 15(1):e04655. PMC: 7010130. DOI: 10.2903/j.efsa.2017.4655. View

14.

Zhu J, Zhang L, Hu X, Xiao Y, Chen J, Xu Y . Correlation of dietary aflatoxin B1 levels with excretion of aflatoxin M1 in human urine. Cancer Res. 1987; 47(7):1848-52. View

15.

Turner P, Hopton R, Lecluse Y, White K, Fisher J, Lebailly P . Determinants of urinary deoxynivalenol and de-epoxy deoxynivalenol in male farmers from Normandy, France. J Agric Food Chem. 2010; 58(8):5206-12. DOI: 10.1021/jf100892v. View

16.

Palumbo R, Crisci A, Venancio A, Abrahantes J, Dorne J, Battilani P . Occurrence and Co-Occurrence of Mycotoxins in Cereal-Based Feed and Food. Microorganisms. 2020; 8(1). PMC: 7023405. DOI: 10.3390/microorganisms8010074. View

17.

Apel P, Angerer J, Wilhelm M, Kolossa-Gehring M . New HBM values for emerging substances, inventory of reference and HBM values in force, and working principles of the German Human Biomonitoring Commission. Int J Hyg Environ Health. 2016; 220(2 Pt A):152-166. DOI: 10.1016/j.ijheh.2016.09.007. View

18.

Mukherjee D, Royce S, Alexander J, Buckley B, Isukapalli S, Bandera E . Physiologically-based toxicokinetic modeling of zearalenone and its metabolites: application to the Jersey girl study. PLoS One. 2014; 9(12):e113632. PMC: 4256163. DOI: 10.1371/journal.pone.0113632. View

19.

Knutsen H, Alexander J, Barregard L, Bignami M, Bruschweiler B, Ceccatelli S . Risks for animal health related to the presence of fumonisins, their modified forms and hidden forms in feed. EFSA J. 2020; 16(5):e05242. PMC: 7009563. DOI: 10.2903/j.efsa.2018.5242. View

20.

Davillas A, Jones A . Parametric models for biomarkers based on flexible size distributions. Health Econ. 2018; 27(10):1617-1624. PMC: 6175412. DOI: 10.1002/hec.3787. View